[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 44, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 34, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.23, "open": 1.24, "dayLow": 1.165, "dayHigh": 1.24, "regularMarketPreviousClose": 1.23, "regularMarketOpen": 1.24, "regularMarketDayLow": 1.165, "regularMarketDayHigh": 1.24, "payoutRatio": 0.0, "beta": 1.454, "forwardPE": -0.8150685, "volume": 78705, "regularMarketVolume": 78705, "averageVolume": 1218912, "averageVolume10days": 191110, "averageDailyVolume10Day": 191110, "bid": 1.13, "ask": 1.23, "bidSize": 2, "askSize": 2, "marketCap": 13464613, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 5.95, "priceToSalesTrailing12Months": 2.3638206, "fiftyDayAverage": 1.5266, "twoHundredDayAverage": 2.0886, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -228554, "profitMargins": -2.24445, "floatShares": 9404099, "sharesOutstanding": 11314800, "sharesShort": 103075, "sharesShortPriorMonth": 173261, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0091, "heldPercentInsiders": 0.02422, "heldPercentInstitutions": 0.35463002, "shortRatio": 1.07, "shortPercentOfFloat": 0.0679, "impliedSharesOutstanding": 11314800, "bookValue": 1.292, "priceToBook": 0.92105263, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -12784677, "trailingEps": -1.32, "forwardEps": -1.46, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": -0.04, "52WeekChange": -0.6884817, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 1.19, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 13693208, "totalCashPerShare": 1.21, "totalDebt": 0, "quickRatio": 6.457, "currentRatio": 6.794, "totalRevenue": 5696123, "revenuePerShare": 0.598, "returnOnAssets": -0.51168996, "returnOnEquity": -0.97295, "grossProfits": -8332134, "freeCashflow": -7741188, "operatingCashflow": -12572943, "revenueGrowth": -0.719, "grossMargins": -1.46277, "ebitdaMargins": 0.0, "operatingMargins": -11.9034395, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 0.840335, "postMarketPrice": 1.2, "postMarketChange": 0.00999999, "regularMarketChange": -0.04, "regularMarketDayRange": "1.165 - 1.24", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1218912, "fiftyTwoWeekLowChange": 0.24000007, "fiftyTwoWeekLowChangePercent": 0.25263166, "fiftyTwoWeekRange": "0.95 - 5.95", "fiftyTwoWeekHighChange": -4.7599998, "fiftyTwoWeekHighChangePercent": -0.8, "fiftyTwoWeekChangePercent": -68.84817, "dividendDate": 1473984000, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.32, "epsForward": -1.46, "epsCurrentYear": -1.19, "priceEpsCurrentYear": -1.0, "fiftyDayAverageChange": -0.33659995, "fiftyDayAverageChangePercent": -0.22048995, "twoHundredDayAverageChange": -0.89859986, "twoHundredDayAverageChangePercent": -0.4302403, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1754694094, "regularMarketTime": 1754683201, "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.25203, "regularMarketPrice": 1.19, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]